Literature DB >> 6797793

The price of immunotherapy.

I Penn.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 6797793     DOI： 10.1016/s0011-3840(81)80011-1

Source DB:  PubMed          Journal:  Curr Probl Surg        ISSN： 0011-3840            Impact factor:   1.909


× No keyword cloud information.
  10 in total

1.  Factors in the Development of Liver Transplantation.

Authors:  T E Starzl; S Iwatsuki; B W Shaw; R D Gordon; C Esquivel; S Todo; I Kam; S Lynch
Journal:  Transplant Proc       Date:  1985-10       Impact factor: 1.066

2.  Smooth muscle tumor arising de novo in a liver allograft: A case report.

Authors:  Howard Doyle; Andreas G Tzakis; Eduardo Yunis; Thomas E Starzl
Journal:  Clin Transplant       Date:  1991-02       Impact factor: 2.863

3.  Liver transplantation in the ciclosporin era.

Authors:  T E Starzl; S Iwatsuki; B W Shaw; R D Gordon; C Esquivel
Journal:  Prog Allergy       Date:  1986

Review 4.  Immunosuppression and other nonsurgical factors in the improved results of liver transplantation.

Authors:  T E Starzl; S Iwatsuki; B W Shaw; R D Gordon; C O Esquivel
Journal:  Semin Liver Dis       Date:  1985-11       Impact factor: 6.115

5.  Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.

Authors:  T E Starzl; M A Nalesnik; K A Porter; M Ho; S Iwatsuki; B P Griffith; J T Rosenthal; T R Hakala; B W Shaw; R L Hardesty
Journal:  Lancet       Date:  1984-03-17       Impact factor: 79.321

6.  Fever and pulmonary infiltrates in a patient with a renal transplant.

Authors:  J V Hirschmann; J J Plorde; R F Ochi
Journal:  West J Med       Date:  1984-06

7.  Long-term results of cyclosporine-steroid therapy in 131 non-matched cadaveric renal transplants.

Authors:  Robert D Gordon; Thomas E Starzl; Thomas R Hakala; Rodney J Taylor; Gerhard P J Schroter; J Thomas Rosenthal; Richard Well; Shunzaburo Iwatsuki; Barbara J Carpenter
Journal:  Clin Transplant       Date:  1987       Impact factor: 2.863

8.  Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.

Authors:  D W Hanto; K J Gajl-Peczalska; G Frizzera; D C Arthur; H H Balfour; K McClain; R L Simmons; J S Najarian
Journal:  Ann Surg       Date:  1983-09       Impact factor: 12.969

9.  When and How Is It Possible to Stop Therapy in Patients with Lupus Nephritis: A Narrative Review.

Authors:  Gabriella Moroni; Giulia Frontini; Claudio Ponticelli
Journal:  Clin J Am Soc Nephrol       Date:  2021-06-23       Impact factor: 8.237

10.  Are patients with inflammatory eye disease treated with systemic immunosuppressive therapy at increased risk of malignancy?

Authors:  William B Yates; Peter J McCluskey; Denis Wakefield
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-05-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.